IRIS UniCatt

Forgione, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.270
NA - Nord America 1.192
AS - Asia 1.143
SA - Sud America 231
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.872
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.156
DE - Germania 554
SG - Singapore 537
CN - Cina 364
SE - Svezia 195
BR - Brasile 194
UA - Ucraina 89
FR - Francia 81
IE - Irlanda 76
GB - Regno Unito 62
IT - Italia 60
FI - Finlandia 46
ID - Indonesia 41
VN - Vietnam 37
TR - Turchia 34
IN - India 31
RU - Federazione Russa 28
AR - Argentina 24
PL - Polonia 19
KR - Corea 18
BE - Belgio 15
CA - Canada 12
MX - Messico 12
JP - Giappone 11
HK - Hong Kong 10
IQ - Iraq 10
NL - Olanda 10
ZA - Sudafrica 10
BD - Bangladesh 9
CH - Svizzera 8
IR - Iran 8
AT - Austria 7
PK - Pakistan 5
DZ - Algeria 4
ES - Italia 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
MD - Moldavia 3
BZ - Belize 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PY - Paraguay 2
RE - Reunion 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.872
Salva come PNG Salva come JPEG
Città #
Singapore 247
Chandler 181
Ashburn 113
Dublin 76
Hefei 71
Chicago 64
Beijing 56
Jacksonville 51
San Mateo 47
Los Angeles 43
Jakarta 41
Ann Arbor 40
Marseille 38
Nanjing 36
Nürnberg 34
Munich 30
Helsinki 25
Izmir 25
New York 25
Frankfurt am Main 22
Milan 22
Boston 21
Woodbridge 21
Dallas 19
Kent 19
Moscow 19
Dearborn 18
Seoul 18
Wilmington 18
Princeton 17
Brussels 15
Ho Chi Minh City 15
Houston 14
Kraków 13
São Paulo 12
Düsseldorf 10
Tokyo 10
Bremen 9
Hong Kong 9
Nanchang 9
Nuremberg 9
Shenyang 9
Brasília 8
Redwood City 8
Boardman 7
Manaus 7
Poplar 7
Provo 7
Shanghai 7
Zhengzhou 7
Buffalo 6
Cape Town 6
Fremont 6
Hanoi 6
Lauterbourg 6
Phoenix 6
Toronto 6
Utrecht 6
Zurich 6
Brooklyn 5
Jiaxing 5
Jinan 5
Kunming 5
Leawood 5
Pune 5
Rome 5
San Francisco 5
Santa Clara 5
Stockholm 5
Tabriz 5
Baghdad 4
Boydton 4
Charlotte 4
Denver 4
Guangzhou 4
Guarulhos 4
Hangzhou 4
Hebei 4
Orem 4
Salvador 4
Tianjin 4
Turku 4
Vienna 4
Warsaw 4
Ankara 3
Baku 3
Bexley 3
Brno 3
Cattolica 3
Changsha 3
Dhaka 3
Fairfield 3
Johannesburg 3
Jundiaí 3
Medellín 3
Mexico City 3
Miami 3
Mountain View 3
Nairobi 3
Ottawa 3
Totale 1.862
Salva come PNG Salva come JPEG
Nome #
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 228
-Hepatic steatosis and vascular disease 214
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 201
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 186
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 156
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 154
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 153
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 148
-Fatty liver and drugs 143
gastroesophageal reflux disease: facts and uncertaines 139
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 133
Tromboembolism and breast cancer: the hidden risk for patient and physician 131
-Nonalcoholic fatty liver disease: defining a common problem 120
Alcoholic and nonalcoholic forms of fatty liver disease. 115
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 110
Pattern of macrovascular invasion in hepatocellular carcinoma 99
anticholinergic syndrome due to " Devil's herb': when risks come from the ancient time 86
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 82
PREVALENCE OF LIVER STEATOSIS AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 80
Monofocal hepatocellular carcinoma: How much does size matter? 80
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time 67
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 66
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 63
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 63
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 63
Use of G-CSF during acute on chronic liver failure: Clinical and biochemical safety profile 62
CXCR4, vegfr and VLA-4 levels in peripheral blood lymphocytes of patients with acute on chronic liver failure treated with G-CSF 62
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 61
Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity 60
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 59
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 55
G) Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test 54
Thromboembolism and breast cancer: the hidden risk for patient and physician 50
Serum levels of metalloproteinases and their inhibitors in nonalcoholic steatohepatitis 50
Fibrogenesis and fibrosis in nonalcoholic steatohepatitis 49
Eighteen needles to forget...an unnamed past 48
Quantitative liver function tests to assess MEHOS activity in NASH patients 47
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 46
C-Methacetin breath test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy 45
Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH) 38
Nonalcoholic-Steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation 37
Totale 3.903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 11 20 2 26 9 41 10
2021/2022199 4 29 6 23 11 4 2 35 3 14 32 36
2022/2023629 53 65 30 81 58 80 53 43 73 51 32 10
2023/2024329 25 118 4 15 28 31 11 4 0 24 36 33
2024/2025710 11 17 66 8 65 23 17 41 107 59 165 131
2025/2026979 281 71 111 167 281 68 0 0 0 0 0 0
Totale 3.903